Logo Lucerna-Chem
+41 41 420 9636

Regulatory Status

Article Status


Pradefovir mesylate


Catalog Number Pack Size List Price* Promo Price* Quantity
HY-112690A-5MG 5 mg 656,00 557,60 Add
HY-112690A-10MMO 10 mM * 1 mL 750,00 637,50 Add
HY-112690A-10MG 10 mg 935,00 794,80 Add
HY-112690A-25MG 25 mg 1'870,00 1'589,50 Add

* CHF, excl. 7.7% VAT and shipping costs


Product Description

Remofovir mesylate
Pradefovir mesylate is a good substrate for liver CYP3A4. Pradefovir is converted to 9-(2-phosphonylmethoxyethyl)adenine (PMEA) in human liver microsomes with a Km of 60 μM.

Category Biochemicals
Supplier MedChem Express
Application Metabolism-sugar/lipid metabolism
Regulatory Status RUO
Format Solubility: H2O : ≥ 125 mg/mL (240.43 mM)
Grade Clinical information: Phase 2
Purity 99.83%
Molecular Formula C18H23ClN5O7PS
Molecular Weight 519.9
CAS-Number [625095-61-6]
Storage Conditions Powder -20°C 3 years, 4°C 2 years; In solvent -80°C 6 months, -20°C 1 month
Product Line Research
Tech. Data Sheet View datasheet
Link To Supplier http://www.medchemexpress.com
Material Safety Data Sheet Download PDF
Call us

Customer Support
T +41 41 420 96 36
F +41 41 420 96 56
info@lucerna-chem.ch

Business Hours
From Monday through Friday
08:00 – 12:00
13:00 – 17:00

Ask us

Technical Support
tech@lucerna-chem.ch

Business Development
business.dev@lucerna-chem.ch

Postal address
Lucerna-Chem AG
Abendweg 18
CH-6006 Luzern

Newsletter













If you have already subscribed to our newsletter and would like to update your details or cancel it, please click here.


© Copyright 2021 Lucerna-Chem AG, Switzerland